Selected research
Market Outlook & Growth Opportunities
Global Urinary Tract Supplements Market Outlook and Growth Opportunities 2026
Market perspective
The global Urinary Tract Supplements market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Urinary Tract Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Urinary Tract Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Urinary Tract Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Urinary Tract Supplements market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Urinary Tract Supplements market include A.Vogel, DSE Healthcare Solutions, Gaia Herbs, Herbalife, Himalaya Wellness, Holland & Barrett, Life Extension, LoveBug Probiotics and Metabolics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Urinary Tract Supplements market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Urinary Tract Supplements and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Urinary Tract Supplements sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Urinary Tract Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.
Urinary Tract Supplements Segment by Company
A.Vogel
DSE Healthcare Solutions
Gaia Herbs
Herbalife
Himalaya Wellness
Holland & Barrett
Life Extension
LoveBug Probiotics
Metabolics
Natrol
Nature Made
Nature's Answer
Nature's Bounty
Nature's Way
NOW Foods
Olly
Ruhrpharm
S&R Farmaceutici
Solaray
Swisse
The Himalayan Organics
Theralogix
Zahlers
Urinary Tract Supplements Segment by Type
Single-Ingredient
Multi-Ingredient
Urinary Tract Supplements Segment by Application
Online Sales
Offline Sales
Urinary Tract Supplements Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Urinary Tract Supplements status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Urinary Tract Supplements market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Urinary Tract Supplements significant trends, drivers, influence factors in global and regions.
6. To analyze Urinary Tract Supplements competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urinary Tract Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Urinary Tract Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urinary Tract Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Urinary Tract Supplements market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Urinary Tract Supplements industry.
Chapter 3: Detailed analysis of Urinary Tract Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Urinary Tract Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Urinary Tract Supplements in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-Ingredient
- Multi-Ingredient
Applications
- Online Sales
- Offline Sales
Companies covered
- A.Vogel
- DSE Healthcare Solutions
- Gaia Herbs
- Herbalife
- Himalaya Wellness
- Holland & Barrett
- Life Extension
- LoveBug Probiotics
- Metabolics
- Natrol
- Nature Made
- Nature's Answer
- Nature's Bounty
- Nature's Way
- NOW Foods
- Olly
- Ruhrpharm
- S&R Farmaceutici
- Solaray
- Swisse
- The Himalayan Organics
- Theralogix
- Zahlers
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Urinary Tract Supplements Sales Value (2021-2032)
- 1.2.2 Global Urinary Tract Supplements Sales Volume (2021-2032)
- 1.2.3 Global Urinary Tract Supplements Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Urinary Tract Supplements Market Dynamics
- 2.1 Urinary Tract Supplements Industry Trends
- 2.2 Urinary Tract Supplements Industry Drivers
- 2.3 Urinary Tract Supplements Industry Opportunities and Challenges
- 2.4 Urinary Tract Supplements Industry Restraints
3 Urinary Tract Supplements Market by Company
- 3.1 Global Urinary Tract Supplements Company Revenue Ranking in 2025
- 3.2 Global Urinary Tract Supplements Revenue by Company (2021-2026)
- 3.3 Global Urinary Tract Supplements Sales Volume by Company (2021-2026)
- 3.4 Global Urinary Tract Supplements Average Price by Company (2021-2026)
- 3.5 Global Urinary Tract Supplements Company Ranking (2024-2026)
- 3.6 Global Urinary Tract Supplements Company Manufacturing Base and Headquarters
- 3.7 Global Urinary Tract Supplements Company Product Type and Application
- 3.8 Global Urinary Tract Supplements Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Urinary Tract Supplements Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Urinary Tract Supplements Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Urinary Tract Supplements Market by Type
- 4.1 Urinary Tract Supplements Type Introduction
- 4.1.1 Single-Ingredient
- 4.1.2 Multi-Ingredient
- 4.2 Global Urinary Tract Supplements Sales Volume by Type
- 4.2.1 Global Urinary Tract Supplements Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Urinary Tract Supplements Sales Volume by Type (2021-2032)
- 4.2.3 Global Urinary Tract Supplements Sales Volume Share by Type (2021-2032)
- 4.3 Global Urinary Tract Supplements Sales Value by Type
- 4.3.1 Global Urinary Tract Supplements Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Urinary Tract Supplements Sales Value by Type (2021-2032)
- 4.3.3 Global Urinary Tract Supplements Sales Value Share by Type (2021-2032)
5 Urinary Tract Supplements Market by Application
- 5.1 Urinary Tract Supplements Application Introduction
- 5.1.1 Online Sales
- 5.1.2 Offline Sales
- 5.2 Global Urinary Tract Supplements Sales Volume by Application
- 5.2.1 Global Urinary Tract Supplements Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Urinary Tract Supplements Sales Volume by Application (2021-2032)
- 5.2.3 Global Urinary Tract Supplements Sales Volume Share by Application (2021-2032)
- 5.3 Global Urinary Tract Supplements Sales Value by Application
- 5.3.1 Global Urinary Tract Supplements Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Urinary Tract Supplements Sales Value by Application (2021-2032)
- 5.3.3 Global Urinary Tract Supplements Sales Value Share by Application (2021-2032)
6 Urinary Tract Supplements Regional Sales and Value Analysis
- 6.1 Global Urinary Tract Supplements Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Urinary Tract Supplements Sales by Region (2021-2032)
- 6.2.1 Global Urinary Tract Supplements Sales by Region: 2021-2026
- 6.2.2 Global Urinary Tract Supplements Sales by Region (2027-2032)
- 6.3 Global Urinary Tract Supplements Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Urinary Tract Supplements Sales Value by Region (2021-2032)
- 6.4.1 Global Urinary Tract Supplements Sales Value by Region: 2021-2026
- 6.4.2 Global Urinary Tract Supplements Sales Value by Region (2027-2032)
- 6.5 Global Urinary Tract Supplements Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Urinary Tract Supplements Sales Value (2021-2032)
- 6.6.2 North America Urinary Tract Supplements Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Urinary Tract Supplements Sales Value (2021-2032)
- 6.7.2 Europe Urinary Tract Supplements Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Urinary Tract Supplements Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Urinary Tract Supplements Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Urinary Tract Supplements Sales Value (2021-2032)
- 6.9.2 South America Urinary Tract Supplements Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Urinary Tract Supplements Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Urinary Tract Supplements Sales Value Share by Country, 2025 VS 2032
7 Urinary Tract Supplements Country-level Sales and Value Analysis
- 7.1 Global Urinary Tract Supplements Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Urinary Tract Supplements Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Urinary Tract Supplements Sales by Country (2021-2032)
- 7.3.1 Global Urinary Tract Supplements Sales by Country (2021-2026)
- 7.3.2 Global Urinary Tract Supplements Sales by Country (2027-2032)
- 7.4 Global Urinary Tract Supplements Sales Value by Country (2021-2032)
- 7.4.1 Global Urinary Tract Supplements Sales Value by Country (2021-2026)
- 7.4.2 Global Urinary Tract Supplements Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.9.2 France Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.16.2 China Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.19.2 India Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Urinary Tract Supplements Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Urinary Tract Supplements Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Urinary Tract Supplements Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 A.Vogel
- 8.1.1 A.Vogel Company Information
- 8.1.2 A.Vogel Business Overview
- 8.1.3 A.Vogel Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.1.4 A.Vogel Urinary Tract Supplements Product Portfolio
- 8.1.5 A.Vogel Recent Developments
- 8.2 DSE Healthcare Solutions
- 8.2.1 DSE Healthcare Solutions Company Information
- 8.2.2 DSE Healthcare Solutions Business Overview
- 8.2.3 DSE Healthcare Solutions Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.2.4 DSE Healthcare Solutions Urinary Tract Supplements Product Portfolio
- 8.2.5 DSE Healthcare Solutions Recent Developments
- 8.3 Gaia Herbs
- 8.3.1 Gaia Herbs Company Information
- 8.3.2 Gaia Herbs Business Overview
- 8.3.3 Gaia Herbs Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Gaia Herbs Urinary Tract Supplements Product Portfolio
- 8.3.5 Gaia Herbs Recent Developments
- 8.4 Herbalife
- 8.4.1 Herbalife Company Information
- 8.4.2 Herbalife Business Overview
- 8.4.3 Herbalife Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Herbalife Urinary Tract Supplements Product Portfolio
- 8.4.5 Herbalife Recent Developments
- 8.5 Himalaya Wellness
- 8.5.1 Himalaya Wellness Company Information
- 8.5.2 Himalaya Wellness Business Overview
- 8.5.3 Himalaya Wellness Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Himalaya Wellness Urinary Tract Supplements Product Portfolio
- 8.5.5 Himalaya Wellness Recent Developments
- 8.6 Holland & Barrett
- 8.6.1 Holland & Barrett Company Information
- 8.6.2 Holland & Barrett Business Overview
- 8.6.3 Holland & Barrett Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Holland & Barrett Urinary Tract Supplements Product Portfolio
- 8.6.5 Holland & Barrett Recent Developments
- 8.7 Life Extension
- 8.7.1 Life Extension Company Information
- 8.7.2 Life Extension Business Overview
- 8.7.3 Life Extension Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Life Extension Urinary Tract Supplements Product Portfolio
- 8.7.5 Life Extension Recent Developments
- 8.8 LoveBug Probiotics
- 8.8.1 LoveBug Probiotics Company Information
- 8.8.2 LoveBug Probiotics Business Overview
- 8.8.3 LoveBug Probiotics Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.8.4 LoveBug Probiotics Urinary Tract Supplements Product Portfolio
- 8.8.5 LoveBug Probiotics Recent Developments
- 8.9 Metabolics
- 8.9.1 Metabolics Company Information
- 8.9.2 Metabolics Business Overview
- 8.9.3 Metabolics Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Metabolics Urinary Tract Supplements Product Portfolio
- 8.9.5 Metabolics Recent Developments
- 8.10 Natrol
- 8.10.1 Natrol Company Information
- 8.10.2 Natrol Business Overview
- 8.10.3 Natrol Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Natrol Urinary Tract Supplements Product Portfolio
- 8.10.5 Natrol Recent Developments
- 8.11 Nature Made
- 8.11.1 Nature Made Company Information
- 8.11.2 Nature Made Business Overview
- 8.11.3 Nature Made Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Nature Made Urinary Tract Supplements Product Portfolio
- 8.11.5 Nature Made Recent Developments
- 8.12 Nature's Answer
- 8.12.1 Nature's Answer Company Information
- 8.12.2 Nature's Answer Business Overview
- 8.12.3 Nature's Answer Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Nature's Answer Urinary Tract Supplements Product Portfolio
- 8.12.5 Nature's Answer Recent Developments
- 8.13 Nature's Bounty
- 8.13.1 Nature's Bounty Company Information
- 8.13.2 Nature's Bounty Business Overview
- 8.13.3 Nature's Bounty Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Nature's Bounty Urinary Tract Supplements Product Portfolio
- 8.13.5 Nature's Bounty Recent Developments
- 8.14 Nature's Way
- 8.14.1 Nature's Way Company Information
- 8.14.2 Nature's Way Business Overview
- 8.14.3 Nature's Way Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Nature's Way Urinary Tract Supplements Product Portfolio
- 8.14.5 Nature's Way Recent Developments
- 8.15 NOW Foods
- 8.15.1 NOW Foods Company Information
- 8.15.2 NOW Foods Business Overview
- 8.15.3 NOW Foods Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.15.4 NOW Foods Urinary Tract Supplements Product Portfolio
- 8.15.5 NOW Foods Recent Developments
- 8.16 Olly
- 8.16.1 Olly Company Information
- 8.16.2 Olly Business Overview
- 8.16.3 Olly Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Olly Urinary Tract Supplements Product Portfolio
- 8.16.5 Olly Recent Developments
- 8.17 Ruhrpharm
- 8.17.1 Ruhrpharm Company Information
- 8.17.2 Ruhrpharm Business Overview
- 8.17.3 Ruhrpharm Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Ruhrpharm Urinary Tract Supplements Product Portfolio
- 8.17.5 Ruhrpharm Recent Developments
- 8.18 S&R Farmaceutici
- 8.18.1 S&R Farmaceutici Company Information
- 8.18.2 S&R Farmaceutici Business Overview
- 8.18.3 S&R Farmaceutici Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.18.4 S&R Farmaceutici Urinary Tract Supplements Product Portfolio
- 8.18.5 S&R Farmaceutici Recent Developments
- 8.19 Solaray
- 8.19.1 Solaray Company Information
- 8.19.2 Solaray Business Overview
- 8.19.3 Solaray Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Solaray Urinary Tract Supplements Product Portfolio
- 8.19.5 Solaray Recent Developments
- 8.20 Swisse
- 8.20.1 Swisse Company Information
- 8.20.2 Swisse Business Overview
- 8.20.3 Swisse Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Swisse Urinary Tract Supplements Product Portfolio
- 8.20.5 Swisse Recent Developments
- 8.21 The Himalayan Organics
- 8.21.1 The Himalayan Organics Company Information
- 8.21.2 The Himalayan Organics Business Overview
- 8.21.3 The Himalayan Organics Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.21.4 The Himalayan Organics Urinary Tract Supplements Product Portfolio
- 8.21.5 The Himalayan Organics Recent Developments
- 8.22 Theralogix
- 8.22.1 Theralogix Company Information
- 8.22.2 Theralogix Business Overview
- 8.22.3 Theralogix Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.22.4 Theralogix Urinary Tract Supplements Product Portfolio
- 8.22.5 Theralogix Recent Developments
- 8.23 Zahlers
- 8.23.1 Zahlers Company Information
- 8.23.2 Zahlers Business Overview
- 8.23.3 Zahlers Urinary Tract Supplements Sales, Value and Gross Margin (2021-2026)
- 8.23.4 Zahlers Urinary Tract Supplements Product Portfolio
- 8.23.5 Zahlers Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Urinary Tract Supplements Value Chain Analysis
- 9.1.1 Urinary Tract Supplements Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Urinary Tract Supplements Sales Mode & Process
- 9.2 Urinary Tract Supplements Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Urinary Tract Supplements Distributors
- 9.2.3 Urinary Tract Supplements Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst